Meilleure Health International Industry Group Limited (SEHK: 2327) issued an announcement regarding a delay in the despatch of a circular initially expected by 6 February 2026. The document relates to the recently announced discloseable and connected transaction involving an equity interest transfer agreement dated 8 January 2026.

According to the announcement, additional time is required to prepare and finalize certain information to be included in the circular, which contains details of the agreement, a letter of recommendation from the Independent Board Committee, advice from the Independent Financial Adviser, and a valuation report. The new despatch date for the circular is on or before 6 March 2026.

The board of Meilleure Health comprises executive directors, including Mr. Zhou Xuzhou, Dr. Zeng Wentao, and Ms. Zhou Wen Chuan, one non-executive director, and independent non-executive directors. No further revisions to the terms of the transaction were announced, and the company will provide additional updates if necessary.